Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eleanor De Groot"'
Autor:
Harjeet Singh, Samer A. Srour, Denái R. Milton, Jessica McCarty, Cuiping Dai, Mahmoud R. Gaballa, Mariam Ammari, Simon Olivares, Helen Huls, Eleanor De Groot, David Marin, Demetrios Petropoulos, Amanda L. Olson, Paolo Anderlini, Jin S. Im, Issa Khouri, Chitra M. Hosing, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Laurence J. N. Cooper, Partow Kebriaei
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor (CAR) T-cell therapy has emerged recently as a standard of care treatment for patients with relapsed or refractory acute lymphoblastic leukemia (ALL) and several subtypes of B-cell non-Hodgkin lymphoma (NHL). However, its us
Externí odkaz:
https://doaj.org/article/9569f80e06114c10ac15c8046aef34f8
Autor:
David Torres, Yaoyao Shi, Drew Deniger, Thomas Hunt, Ana Korngold, Lin-Kin Yong, Ugochi Ibekwe, Julissa Simmons, Phillip Eckels, Elizabeth Figueroa, Michelle Hotard, Frances Adeyemi, Tegan Markus, Lenka Hurton, Matthew Collinson-Pautz, Priya Balasubramanian, Cathy Wang, Jourdan Andersson, Lauren Heese, Mariam Khalil, Emarco Olivares, Geraldine Bardelli, Kelly O’Brien, Haroon Hashmi, Alena Chekmasova, Raffaele Baffa, Tom Spencer, Eleanor De Groot
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/645a0ab3cba3400f9d74661ac45f0163
Autor:
Ana Beatriz Korngold, Michelle Hotard, Priya Balasubramanian, Phillip Eckels, Tom Spencer, Drew C. Deniger, Matthew R. Collinson-Pautz, Ugochi Ibekwe, Lin-Kin Yong, Thomas Hunt, Frances Adeyemi, Cathy Wang, Jourdan Andersson, Yaoyao Shi, Lenka V. Hurton, Elizabeth Figueroa, Haroon Hashmi, Mariam Khalil, Kelly O’Brien, Lauren Heese, Alena A Chekmasova, Emarco Olivares, Raffaele Baffa, David Torres, Eleanor De Groot, Julissa Simmons, Tegan Markus, Geraldine Bardelli
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundEGFR, KRAS and TP53 have frequent somatic hotspot mutations giving rise to biologically relevant amino acid substitutions in EGFR, KRAS and p53 proteins, respectively, that can be processed and presented on the cell surface by human leukocy
Autor:
Marcelo Vailati Negrao, Maria Pia Morelli, Amir A. Jazaeri, Benny Johnson, Partow Kebriaei, Drew Deninger, Eleanor De Groot, Matthew R. Collinson-Pautz, Nathan A. Demars, Jaymes S. Holland, John Heymach, Raffaele Baffa, Scott Kopetz
Publikováno v:
Journal of Clinical Oncology. 40:TPS2679-TPS2679
TPS2679 Background: In 2022 approximately 1.7 million Americans will die from solid cancers. Recently there have been significant advances in the genetic engineering of T lymphocytes to recognize neoantigens on tumors in vivo, resulting in remarkable
Autor:
Ana Beatriz Korngold, Matthew R. Collinson-Pautz, Ming Zhang, Laurence J.N. Cooper, Lin-Kin Yong, Drew C. Deniger, Eleanor De Groot, Yaoyao Shi, Ugochi Ibekwe, Julissa Simmons, Lenka V. Hurton
Publikováno v:
Cancer Research. 81:1515-1515
Mutations in critical genes for cell survival and proliferation, e.g., KRAS and TP53, are found as clonal events in multiple tumor types of unrelated people likely due to their importance to the malignant phenotype. T cells recognize products of muta
Publikováno v:
Clinical Pharmacology in Drug Development
Cachexia occurs in up to 80% of patients with advanced cancer and is characterized by involuntary weight loss, frequently accompanied by anorexia and altered metabolism.1–5 It is associated with poorer survival, a decline in physical functioning an